Published on in Vol 10, No 9 (2021): September
Preprints (earlier versions) of this paper are
available at
https://preprints.jmir.org/preprint/31439, first published
.
![The Safety and Efficacy of Microbial Ecosystem Therapeutic-2 in People With Major Depression: Protocol for a Phase 2, Double-Blind, Placebo-Controlled Study The Safety and Efficacy of Microbial Ecosystem Therapeutic-2 in People With Major Depression: Protocol for a Phase 2, Double-Blind, Placebo-Controlled Study](https://asset.jmir.pub/assets/31a782a44b826bfbb09b196c3d35a371.png 480w,https://asset.jmir.pub/assets/31a782a44b826bfbb09b196c3d35a371.png 960w,https://asset.jmir.pub/assets/31a782a44b826bfbb09b196c3d35a371.png 1920w,https://asset.jmir.pub/assets/31a782a44b826bfbb09b196c3d35a371.png 2500w)
Journals
- Han W, Wang N, Han M, Ban M, Sun T, Xu J. Reviewing the role of gut microbiota in the pathogenesis of depression and exploring new therapeutic options. Frontiers in Neuroscience 2022;16 View
- Alshrari A, Hudu S, Elmigdadi F, Imran M. The Urgent Threat of Clostridioides difficile Infection: A Glimpse of the Drugs of the Future, with Related Patents and Prospects. Biomedicines 2023;11(2):426 View
- Mörkl S, Butler M, Lackner S. Advances in the gut microbiome and mood disorders. Current Opinion in Psychiatry 2023;36(1):1 View
- Li S, Zhang Y. Sensitive delivery systems and novel encapsulation technologies for live biotherapeutic products and probiotics. Critical Reviews in Microbiology 2024;50(3):371 View
- Varesi A, Campagnoli L, Chirumbolo S, Candiano B, Carrara A, Ricevuti G, Esposito C, Pascale A. The brain-gut-microbiota interplay in depression: A key to design innovative therapeutic approaches. Pharmacological Research 2023;192:106799 View